Neurogene, Inc. Common Stock (NGNE) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for NGNE. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 108 institutions reported holding NGNE, with 17.3 million shares worth $544.4 million in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Samsara Biocapital | 1,717,127 | $54M | UNCHANGED |
| Casdin Capital | 1,545,361 | $49M | INCREASED |
| Redmile Group | 1,412,199 | $44M | DECREASED |
| Rtw Investments | 1,362,456 | $43M | UNCHANGED |
| Ecor1 Capital | 1,271,342 | $40M | UNCHANGED |
Full institutional holdings, insider history, and congressional trades for Neurogene, Inc. Common Stock on SentiSense.